Financials data is unavailable for this security.
View more
Year on year Elan Corp grew revenues 14.23% from 36.26bn to 41.43bn while net income improved 20.94% from 2.08bn to 2.52bn.
Gross margin | 23.06% |
---|---|
Net profit margin | 5.37% |
Operating margin | 7.99% |
Return on assets | 13.14% |
---|---|
Return on equity | 22.31% |
Return on investment | 22.04% |
More ▼
Cash flow in JPYView more
In 2023, cash reserves at Elan Corp fell by 547.46m. However, the company earned 1.78bn from its operations for a Cash Flow Margin of 4.30%. In addition the company used 1.66bn on investing activities and also paid 667.09m in financing cash flows.
Cash flow per share | 49.83 |
---|---|
Price/Cash flow per share | 14.46 |
Book value per share | 196.49 |
---|---|
Tangible book value per share | 181.88 |
More ▼
Balance sheet in JPYView more
Current ratio | 1.96 |
---|---|
Quick ratio | 1.72 |
Total debt/total equity | 0.011 |
---|---|
Total debt/total capital | 0.0109 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 18.18% and 20.93%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Healthcare Facilities industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg) | 0.81% |
---|---|
Div growth rate (5 year) | 30.01% |
Payout ratio (TTM) | 31.99% |
EPS growth(5 years) | 23.88 |
---|---|
EPS (TTM) vs TTM 1 year ago | 11.53 |
More ▼